Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells

被引:66
作者
Fillebeen, Carine [1 ]
Pantopoulos, Kostas [1 ,2 ]
机构
[1] Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3A 2T5, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Hepatitis C virus; Iron metabolism; NS5B; N53; Ferrtin; Transferrin receptor 1; HEPCIDIN EXPRESSION; MEDICAL PROGRESS; HFE GENE; HEMOCHROMATOSIS; SYSTEM; LIVER; HCV; INTERFERON; METABOLISM; RIBAVIRIN;
D O I
10.1016/j.jhep.2010.04.044
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background & Aims Chronic infection with hepatitis C virus (HCV) is often associated with elevated hepatic iron levels Excess iron is known to promote oxidative stress and exacerbate liver disease Nevertheless biochemical studies in subgenomic HCV replicon systems showed that iron can also suppress the expression of viral RNA and proteins by inhibiting the enzymatic activity of the RNA polymerase NS5B To explore the physiological relevance of this response we evaluated the effects of iron during infection of permissive Huh7 5 1 hepatoma cells with HCV Methods We utilized Fe-SIH (Iron complexed with salicylaldehyde isonicotinoyl hydrazone) a cell permeable and highly efficient iron donor Results Treatments of Infected cells with Fe-SIH drastically reduced the expression of viral proteins (core and NS3) and RNA in a dose-dependent manner The inhibition was dramatic when Fe-SIH was administered simultaneously with the HCV inoculum or early afterwards while pre-treatment of cells with Fe-SIH before infection failed to elicit antiviral responses Iron chelation with SIH did not significantly alter the expression of viral proteins Conclusions Our data establish a critical role of hepatic Iron concentration on the progression of HCV infection and are consistent with iron-mediated inactivation of NS5B (C) 2010 European Association for the Study of the Liver Published by Elsevier B V All rights reserved
引用
收藏
页码:995 / 999
页数:5
相关论文
共 41 条
[1]
Iron in nonhemochromatotic liver disorders [J].
Alla, V ;
Bonkovsky, HL .
SEMINARS IN LIVER DISEASE, 2005, 25 (04) :461-472
[2]
Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[3]
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C [J].
Bonkovsky, Herbert L. ;
Naishadham, Deepa ;
Lambrecht, Richard W. ;
Chung, Raymond T. ;
Hoefs, John C. ;
Nash, S. Russell ;
Rogers, Thomas E. ;
Banner, Barbara F. ;
Sterling, Richard K. ;
Donovan, John A. ;
Fontana, Robert J. ;
Di Bisceglie, Adrian M. ;
Ghany, Marc G. ;
Morishima, Chihiro .
GASTROENTEROLOGY, 2006, 131 (05) :1440-1451
[4]
Buss JL, 2002, ADV EXP MED BIOL, V509, P205
[5]
HFE cross-talks with the MHC class I antigen presentation pathway [J].
de Almeida, SF ;
Carvalho, IF ;
Cardoso, CS ;
Cordeiro, JV ;
Azevedo, JE ;
Neefjes, J ;
de Sousa, M .
BLOOD, 2005, 106 (03) :971-977
[6]
Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection [J].
Distante, S ;
Bjoro, K ;
Hellum, KB ;
Myrvang, B ;
Berg, JP ;
Skaug, K ;
Raknerud, N ;
Bell, H .
LIVER, 2002, 22 (03) :269-275
[7]
Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C virus [J].
Fillebeen, C ;
Rivas-Estilla, AM ;
Bisaillon, M ;
Ponka, P ;
Muckenthaler, M ;
Hentze, MW ;
Koromilas, AE ;
Pantopoulos, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) :9049-9057
[8]
Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells [J].
Fillebeen, Carine ;
Muckenthaler, Martina ;
Andricipoulos, Bill ;
Bisaillon, Martin ;
Mounir, Zineb ;
Hentze, Matthias W. ;
Koromilas, Antonis E. ;
Pantopoulos, Kostas .
JOURNAL OF HEPATOLOGY, 2007, 47 (01) :12-22
[9]
Hepcidin expression in the liver: Relatively low level in patients with chronic hepatitis C [J].
Fujita, Naoki ;
Sugimoto, Ryosuke ;
Takeo, Masaki ;
Urawa, Naohito ;
Mifuji, Rumi ;
Tanaka, Hideaki ;
Kobayashi, Yoshinao ;
Iwasa, Motoh ;
Watanabe, Shozo ;
Adachi, Yukihiko ;
Kaito, Masahiko .
MOLECULAR MEDICINE, 2007, 13 (1-2) :97-104
[10]
Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia [J].
Harmatz, Paul ;
Jonas, Maureen M. ;
Kwiatkowski, Janet L. ;
Wright, Elizabeth C. ;
Fischer, Roland ;
Vichinsky, Elliott ;
Giardina, Patricia J. ;
Neufeld, Ellis J. ;
Porter, John ;
Olivieril, Nancy .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08) :1247-1251